相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence
I. Bruns et al.
LEUKEMIA (2009)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
Getting to the stem of chronic myeloid leukaemia
Michael Savona et al.
NATURE REVIEWS CANCER (2008)
Why is PTEN an important tumor suppressor?
Li Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
RAS/ERK modulates TGFβ-regulated PTEN expression in human pancreatic adenocarcinoma cells
Jimmy Y. C. Chow et al.
CARCINOGENESIS (2007)
PTEN is destabilized by phosphorylation on Thr366
Helene Maccario et al.
BIOCHEMICAL JOURNAL (2007)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells
Cong Peng et al.
BLOOD (2007)
Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NFκB-dependent pathway
Dianren Xia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Ubiquitination regulates PTEN nuclear import and tumor suppression
Lloyd C. Trotman et al.
CELL (2007)
Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice
Yiguo Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN
Lenin Mahimainathan et al.
DIABETES (2006)
The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice
Mei-Ling Chen et al.
GENES & DEVELOPMENT (2006)
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Omer H. Yilmaz et al.
NATURE (2006)
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention
Jiwang Zhang et al.
NATURE (2006)
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
P Neviani et al.
CANCER CELL (2005)
Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners
P Várnai et al.
JOURNAL OF CELL SCIENCE (2005)
Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor κB induced by UV radiation
J Wang et al.
CANCER RESEARCH (2005)
The BCR-ABL story: Bench to bedside and back
S Wong et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells
WD Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
BCR/ABL activates mdm2 rnRNA translation via the La antigen
R Trotta et al.
CANCER CELL (2003)
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia
NP Shah et al.
CANCER CELL (2002)
Cre/LoxP-mediated inactivation of the murine Pten tumor suppressor gene
R Lesche et al.
GENESIS (2002)
Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro
SM Graham et al.
BLOOD (2002)
The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling
T Virolle et al.
NATURE CELL BIOLOGY (2001)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Regulation of PTEN transcription by p53
V Stambolic et al.
MOLECULAR CELL (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus - Implications for PTEN stability to proteasome-mediated degradation
J Torres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Alterations of P53 and RB genes and the evolution of the accelerated phase of chronic myeloid leukemia
Z Beck et al.
LEUKEMIA & LYMPHOMA (2000)
Phosphorylation of the PTEN tail regulates protein stability and function
F Vazquez et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
The tyrosine kinase inhibitor STI571, like interferon-α, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia
SB Marley et al.
EXPERIMENTAL HEMATOLOGY (2000)
Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder
SX Hao et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
